Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-20-010317
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-11 20:52:13
Reporting Period:
2020-03-09
Accepted Time:
2020-03-11 20:52:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Bausch Health Companies Inc. BHC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1681871 Christina Ackermann 400 Somerset Corporate Boulevard
Bridgewater NJ 08807
Evp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Disposition 2020-03-09 3,343 $20.96 87,245 No 4 F Direct
Common Shares, No Par Value Acquisiton 2020-03-10 4,390 $18.25 91,635 No 4 P Direct
Common Shares, No Par Value Acquisiton 2020-03-10 4,390 $0.00 96,025 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 P Direct
No 4 A Direct
Footnotes
  1. This number represents common shares, no par value, of the Issuer ("Common Shares") withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
  2. The price reported above is a weighted average price. This transaction was executed in multiple trades at prices ranging from 18.23 to $18.25. Information regarding the number of shares purchased and the purchase price per share will be provided upon request by the Commission staff, the Issuer or a shareholder of the Issuer.
  3. Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares reported on Table I above, pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the Reporting Person's continued service (except in limited circumstances).